DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Hijazi Z, Siegbahn A, Andersson U. et al.
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other
Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Circulation 2014;
129: 625-634
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.